Biology Reference
In-Depth Information
Reeves MB, MacAry PA, Lehner PJ, Sissons JG, Sinclair JH (2005b) Latency, chromatin remodeling,
and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl
Acad Sci USA 102:4140-4145
Reeves M, Murphy J, Greaves R, Fairley J, Brehm A, Sinclair J (2006) Autorepression of the human
cytomegalovirus major immediate-early promoter/enhancer at late times of infection is mediated
by the recruitment of chromatin remodeling enzymes by IE86. J Virol 80:9998-10009
Reinhardt B, Winkler M, Schaarschmidt P, Pretsch R, Zhou S, Vaida B, Schmid-Kotsas A, Michel D,
Walther P, Bachem M, Mertens T (2006) Human cytomegalovirus-induced reduction of
extracellular matrix proteins in vascular smooth muscle cell cultures: a pathomechanism in
vasculopathies? J Gen Virol 87:2849-2858
Riddell SR, Rabin M, Geballe AP, Britt WJ, Greenberg PD (1991) Class I MHC-restricted
cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not
require endogenous viral gene expression. J Immunol 146:2795-2804
Rubin RH (1990) Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect
Dis 12 [Suppl 7]:S754-S766
Schierling K, Stamminger T, Mertens T, Winkler M (2004) Human cytomegalovirus tegument
proteins ppUL82 (pp71) and ppUL35 interact and cooperatively activate the major immediate-early
enhancer. J Virol 78:9512-9523
Simmen KA, Singh J, Luukkonen BG, Lopper M, Bittner A, Miller NE, Jackson MR, Compton T,
Fruh K (2001) Global modulation of cellular transcription by human cytomegalovirus is
initiated by viral glycoprotein B. Proc Natl Acad Sci USA 98:7140-7145
Sinclair J, Sissons P (1996) Latent and persistent infections of monocytes and macrophages.
Intervirology 39:293-301
Sinclair J, Sissons P (2006) Latency and reactivation of human cytomegalovirus. J Gen Virol
87:1763-1779
Sindre H, Tjoonnfjord GE, Rollag H, Ranneberg-Nilsen T, Veiby OP, Beck S, Degre M, Hestdal K
(1996) Human cytomegalovirus suppression of and latency in early hematopoietic progenitor
cells. Blood 88:4526-4533
Sinzger C, Grefte A, Plachter B, Gouw AS, The TH, Jahn G (1995) Fibroblasts, epithelial cells,
endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infec-
tion in lung and gastrointestinal tissues. J Gen Virol 76:741-750
Sissons JG, Carmichael AJ (2002) Clinical aspects and management of cytomegalovirus infection.
J Infect 44:78-83
Sissons JG, Bain M, Wills MR (2002) Latency and reactivation of human cytomegalovirus.
J Infect 44:73-77
Slobedman B, Mocarski ES (1999) Quantitative analysis of latent human cytomegalovirus. J Virol
73:4806-4812
Slobedman B, Mocarski ES, Arvin AM, Mellins ED, Abendroth A (2002) Latent cytomegalovirus
down-regulates major histocompatibility complex class II expression on myeloid progenitors.
Blood 100:2867-2873
Slobedman B, Stern JL, Cunningham AL, Abendroth A, Abate DA, Mocarski ES (2004) Impact
of human cytomegalovirus latent infection on myeloid progenitor cell gene expression. J Virol
78:4054-4062
Soderberg-Naucler C, Fish KN, Nelson JA (1997) Reactivation of latent human cytomegalovirus
by allogeneic stimulation of blood cells from healthy donors. Cell 91:119-126
Soderberg-Naucler C, Streblow DN, Fish KN, Allan-Yorke J, Smith PP, Nelson JA (2001)
Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation
dependent. J Virol 75:7543-7554
Spencer JV, Lockridge KM, Barry PA, Lin G, Tsang M, Penfold ME, Schall TJ (2002) Potent
immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J Virol
76:1285-1292
Stanier P, Kitchen AD, Taylor DL, Tyms AS (1992) Detection of human cytomegalovirus in
peripheral mononuclear cells and urine samples using PCR. Mol Cell Probes 6:51-58
